Suppr超能文献

嗜酸性粒细胞增多症(米色)中性粒细胞中弹性蛋白酶和组织蛋白酶G的抑制剂

Inhibitors of elastase and cathepsin G in Chédiak-Higashi (beige) neutrophils.

作者信息

Takeuchi K H, Swank R T

机构信息

Roswell Park Memorial Institute, Department of Molecular and Cellular Biology, Buffalo, New York 14263.

出版信息

J Biol Chem. 1989 May 5;264(13):7431-6.

PMID:2708370
Abstract

Previous studies have established that mature neutrophils from the peritoneal cavity, blood, and bone marrow of beige (Chédiak-Higashi syndrome) mice essentially lack activities of two lysosomal proteinases: elastase and cathepsin G. There are, however, significant levels of each enzyme in early neutrophil precursors in bone marrow. In the present experiments, it was found that the addition of extracts from mature beige neutrophils to extracts of normal neutrophils or to purified human neutrophil elastase and cathepsin G resulted in a significant inhibition of elastase and cathepsin G G activities. 125I-Labeled human neutrophil elastase formed high molecular mass complexes at 64 and 52 kDa on sodium dodecyl sulfate-polyacrylamide gel electrophoresis when added to beige neutrophil extracts. The molecular masses of the inhibitor-125I-elastase complexes suggested that the molecular masses of the inhibitors are approximately 36 and 24 kDa, respectively. These results were confirmed by gel filtration on Superose 12 under nondenaturing conditions. Cathepsin G was inhibited only by the 36-kDa component. The inhibitors formed a covalent complex with the active sites of elastase and cathepsin G. No inhibitory activity was present in mature neutrophil extracts of genetically normal mice or in extracts of bone marrow of beige mice. These results thus represent an unusual example of an enzyme deficiency state caused by the presence of excess inhibitors. Inactivation of neutrophil elastase and cathepsin G in mature circulating and tissue neutrophils may contribute to the increased susceptibility of Chédiak-Higashi patients to infection.

摘要

先前的研究已经证实,来自米色(切迪阿克-希加什综合征)小鼠腹腔、血液和骨髓的成熟中性粒细胞基本上缺乏两种溶酶体蛋白酶的活性:弹性蛋白酶和组织蛋白酶G。然而,骨髓中早期中性粒细胞前体中每种酶的水平都很高。在本实验中,发现将成熟米色中性粒细胞的提取物添加到正常中性粒细胞的提取物中,或添加到纯化的人中性粒细胞弹性蛋白酶和组织蛋白酶G中,会导致弹性蛋白酶和组织蛋白酶G的活性受到显著抑制。当将125I标记的人中性粒细胞弹性蛋白酶添加到米色中性粒细胞提取物中时,在十二烷基硫酸钠-聚丙烯酰胺凝胶电泳上形成了分子量为64 kDa和52 kDa的高分子量复合物。抑制剂-125I-弹性蛋白酶复合物的分子量表明,抑制剂的分子量分别约为36 kDa和24 kDa。这些结果在非变性条件下通过Superose 12凝胶过滤得到了证实。组织蛋白酶G仅被36 kDa的组分抑制。这些抑制剂与弹性蛋白酶和组织蛋白酶G的活性位点形成了共价复合物。在基因正常小鼠的成熟中性粒细胞提取物或米色小鼠的骨髓提取物中均不存在抑制活性。因此,这些结果代表了一个由过量抑制剂导致酶缺乏状态的不寻常例子。成熟循环和组织中性粒细胞中中性粒细胞弹性蛋白酶和组织蛋白酶G的失活可能导致切迪阿克-希加什患者对感染的易感性增加。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验